BCRX holders · Bridgewater Associates, LP 13F · BCRX stock
Bridgewater Associates, LP BioCryst Pharmaceuticals Inc (BCRX) 13F holding
Bridgewater Associates, LP reported 491,057 BCRX shares valued at $4.9M as of 2026-06-30. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars. Cached 13F row, not a live tape.
| Report | Shares | Value | Class |
|---|---|---|---|
| 2026-06-30 | 491,057 | $4.9M | COM |
| 2025-09-30 | 411,503 | $3.1M | COM |
Not investment advice. Cached 13F row, not EDGAR XML.